Trem2 Splicing and Expression are Preserved in a Human Aβ-producing, Rat Knock-in Model of Trem2-R47H Alzheimer's Risk Variant.

Scientific Reports
Marc D Tambini, Luciano D'Adamio

Abstract

The R47H variant of the Triggering-Receptor-Expressed on Myeloid cells 2 (TREM2) increases the risk of Alzheimer's disease (AD). Mutagenesis of exon 2 in Knock-in (KI) mouse models of the R47H variant introduced a cryptic splice site, leading to nonsense mediated decay. Since haploinsufficiency does not model Trem2-R47H function, a new rat KI model, the Trem2R47H KI rat was created. Human Aβ has higher propensity to form toxic Aβ species, which are considered the main pathogenic entity in AD, as compared to rodent Aβ, the rat Amyloid Precursor Protein (App) gene was mutated to produce human Aβ. Trem2 splicing and expression was measured in Trem2R47H KI rat brains and microglia by qualitative and quantitative RT-PCR. Trem2 levels and Trem2 processing was assessed by Western analysis. APP metabolite levels were determined by enzyme-linked immunosorbent assay (ELISA), for Human Aβ and soluble APP, and Western analysis, for full length APP, βCTF and αCTF. Trem2 expression and Trem2 levels are unchanged in Trem2R47H KI rats. The artifactual splicing seen in KI mouse models is not present; additionally, two novel isoforms of rat Trem2 are described. Trem2R47H rat brains have lower human Aβ38, sAPPα and sAPPβ levels. Thus, Trem2R47H K...Continue Reading

References

Apr 10, 1992·Science·J A Hardy, G A Higgins
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·R VidalB Frangione
May 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A BouchonM Colonna
Dec 11, 2002·Journal of Neurochemistry·Christoph D SchmidMonica J Carson
Jul 20, 2005·The Journal of Biological Chemistry·Angeliki FotinopoulouSpiros Efthimiopoulos
Jun 6, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jungsu KimTodd E Golde
Aug 30, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Shuji MatsudaLuciano D'Adamio
Nov 5, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Robert TamayevLuciano D'Adamio
Nov 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Robert TamayevLuciano D'Adamio
Nov 26, 2010·PloS One·Alessia P M BarbagalloLuciano D'Adamio
Apr 28, 2012·Molecular Neurodegeneration·Robert Tamayev, Luciano D'Adamio
Jul 18, 2012·The Journal of Biological Chemistry·Hanna WillanderSara Linse
Nov 16, 2012·The New England Journal of Medicine·Rita GuerreiroUNKNOWN Alzheimer Genetic Analysis Group
Mar 7, 2014·Neurology·Bryan D JamesDavid A Bennett
Jul 6, 2014·Science Translational Medicine·Gernot KleinbergerChristian Haass
Dec 7, 2017·The Journal of Experimental Medicine·Brenda D MooreTodd E Golde
Mar 23, 2018·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lawrence Rajendran, Rosa C Paolicelli
Jun 3, 2018·Molecular Neurodegeneration·Paul J Cheng-HathawayGary E Landreth

❮ Previous
Next ❯

Datasets Mentioned

BETA
MN207145
MN207146

Methods Mentioned

BETA
PCR
flow cytometry
ELISA
transgenic
in vitro transcription
FACS
Reverse
PCRs

Software Mentioned

LinRegPCR
Ensembl
Prism
Image Lab
GraphPad Prism

Related Concepts

Related Feeds

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.